Serious infections during pregnancy may cause maternal and fetal adverse outcomes, and
often require pharmacologic treatment. Physiologic changes during pregnancy may …

Malaria remains a major public health concern for billions of people worldwide. Achieving
the ambitious goal of malaria eradication requires co-ordination of control strategies dealing …

Serious infections can occur during pregnancy, and must be treated to prevent maternal and
fetal adverse outcomes. While some antimicrobials have been studied in pregnancy, many …

Malaria infection during pregnancy has been associated with major adverse health
outcomes for both the mother and the foetus. In 2007, there were an estimated 85 million …

Malaria is still a major health problem, killing approximately 1,600 people each day. The
most vulnerable patient groups are children under the age of five and pregnant women …

Severe malaria in pregnancy is a large contributor to maternal morbidity and mortality.
Intravenous quinine has traditionally been the treatment drug of choice for severe malaria in …

Artemisinin derivatives are key to the current global treatment approach for malaria.
However, much remains unknown regarding the pharmacokinetics of these agents …

Background: Malaria in pregnancy is an important public health problem in sub Saharan
Africa. It is known to be the most common and preventable cause of harmful birth outcomes …

Malaria is the most important parasitic disease in man and it kills approximately 2,000
people each day. Pregnant women are especially vulnerable to malaria with increased …